Advertisement

The Role of Neutrophils in the Immune System: An Overview

  • Harry L. Malech
  • Frank R. DeLeo
  • Mark T. Quinn
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1124)

Abstract

Neutrophils, also known as polymorphonuclear leukocytes (PMNs), have long been considered as the short-lived, nonspecific white cells that form pus—and also happen to kill invading microbes. Indeed, neutrophils were often neglected (and largely not considered) as immune cells. This historic view of neutrophils has changed considerably over the past several decades, and we know now that, in addition to playing the predominant role in the clearance of bacteria and fungi, they play a major role in shaping the host response to infection and immune system homeostasis. The change in our view of the role of neutrophils in the immune system has been due in large part to the study of these cells in vitro. Such work has been made possible by new and/or improved methods and approaches used to investigate neutrophils. These methods are the focus of this volume.

Keywords

Polymorphonuclear leukocyte Granulocyte Neutrophil methods 

References

  1. 1.
    Hoebe K, Janssen E, Beutler B (2004) The interface between innate and adaptive immunity. Nat Immunol 5:971–974PubMedCrossRefGoogle Scholar
  2. 2.
    Babior BM, Kipnes RS, Curnutte JT (1973) Biological defense mechanisms: production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741–744PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Klebanoff SJ (1967) Iodination of bacteria: a bactericidal mechanism. J Exp Med 126:1063–1078PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Lehrer RI, Hanifin J, Cline MJ (1969) Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature 223:78–79PubMedCrossRefGoogle Scholar
  5. 5.
    Bainton DF, Ullyot JL, Farquhar MG (1971) The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 134:907–934PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Bainton DF, Farquhar MG (1968) Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. I. Histochemical staining of bone marrow smears. J Cell Biol 39:286–298PubMedCrossRefGoogle Scholar
  7. 7.
    Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503–3521PubMedGoogle Scholar
  8. 8.
    Segal AW, Abo A (1993) The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 18:43–47PubMedCrossRefGoogle Scholar
  9. 9.
    Babior BM (1999) NADPH oxidase: an update. Blood 93:1464–1476PubMedGoogle Scholar
  10. 10.
    Clark RA (1990) The human neutrophil respiratory burst oxidase. J Infect Dis 161:1140–1147PubMedCrossRefGoogle Scholar
  11. 11.
    Zigmond SH (1978) Chemotaxis by polymorphonuclear leukocytes. J Cell Biol 77:269–287PubMedCrossRefGoogle Scholar
  12. 12.
    Southwick FS, Stossel TP (1983) Contractile proteins in leukocyte function. Semin Hematol 20:305–321PubMedGoogle Scholar
  13. 13.
    Fliedner TM, Cronkite EP, Robertson JS (1964) Granulocytopoiesis. I. Senescence and random loss of neutrophilic granulocytes in human beings. Blood 24:402–414PubMedGoogle Scholar
  14. 14.
    Athens JW, Haab OP, Raab SO et al (1961) Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 40:989–995PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Rossi F, Zatti M (1964) Changes in the metabolic pattern of polymorphonuclear leukocytes during phagocytosis. Br J Exp Pathol 45:548–559PubMedCentralPubMedGoogle Scholar
  16. 16.
    Nauseef WM, Clark RA (2000) Granulocytic phagocytes. In: Mandell GL, Bennett JP, Dolin R (eds) Basic principles in the diagnosis and management of infectious diseases, 5th edn. Churchill Livingstone, New York, pp 89–112Google Scholar
  17. 17.
    Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR (2002) Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci U S A 99:6901–6906PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Theilgaard-Mönch K, Knudsen S, Follin P, Borregaard N (2004) The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 172:7684–7693PubMedGoogle Scholar
  19. 19.
    Zhang XQ, Kluger Y, Nakayama Y et al (2004) Gene expression in mature neutrophils: early responses to inflammatory stimuli. J Leukoc Biol 75:358–372PubMedCrossRefGoogle Scholar
  20. 20.
    Strieter RM, Kasahara K, Allen RM et al (1992) Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 141:397–407PubMedGoogle Scholar
  21. 21.
    Schiffmann E, Corcoran BA, Wahl SM (1975) N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A 72:1059–1062PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Snyderman R, Goetzl EJ (1981) Molecular and cellular mechanisms of leukocyte chemotaxis. Science 213:830–835PubMedCrossRefGoogle Scholar
  23. 23.
    Allen RA, Jesaitis AJ, Cochrane CG (1990) The N-formyl peptide receptor. In: Cochrane CG, Gimbrone MA (eds) Cellular and molecular mechanisms of inflammation: receptors of inflammatory cells, structure–-function relationships. Academic, San Diego, pp 83–112CrossRefGoogle Scholar
  24. 24.
    O'Flaherty JT, Showell HJ, Ward PA (1977) Influence of extracellular Ca2+ and Mg2+ on chemotactic factor-induced neutrophil aggregation. Inflammation 2:265–276PubMedCrossRefGoogle Scholar
  25. 25.
    Serhan CN, Broekman MJ, Korchak HM, Smolen JE, Marcus AJ, Weissmann G (1983) Changes in phosphatidylinositol and phosphatidic acid in stimulated human neutrophils. Relationship to calcium mobilization, aggregation and superoxide radical generation. Biochim Biophys Acta 762:420–428PubMedCrossRefGoogle Scholar
  26. 26.
    McPhail LC, Clayton CC, Snyderman R (1984) A potential second messenger role for unsaturated fatty acids: activation of Ca++-dependent protein kinase. Science 224:622–625PubMedCrossRefGoogle Scholar
  27. 27.
    Aharoni I, Pick E (1990) Activation of the superoxide-generating NADPH oxidase of macrophages by sodium dodecyl sulfate in a soluble cell-free system: evidence for involvement of a G protein. J Leukoc Biol 48:107–115PubMedGoogle Scholar
  28. 28.
    Quinn MT, Parkos CA, Walker L, Orkin SH, Dinauer MC, Jesaitis AJ (1989) Association of a ras-related protein with cytochrome b of human neutrophils. Nature 342:198–200PubMedCrossRefGoogle Scholar
  29. 29.
    Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW (1991) Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668–670PubMedCrossRefGoogle Scholar
  30. 30.
    Knaus UG, Heyworth PG, Evans T, Curnutte JT, Bokoch GM (1991) Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac2. Science 254:1512–1515PubMedCrossRefGoogle Scholar
  31. 31.
    Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191–1197PubMedCrossRefGoogle Scholar
  32. 32.
    Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865–875PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Whyte MK, Meagher LC, MacDermot J, Haslett C (1993) Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150:5124–5134PubMedGoogle Scholar
  34. 34.
    DeLeo FR (2004) Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 9:399–413PubMedCrossRefGoogle Scholar
  35. 35.
    Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535PubMedCrossRefGoogle Scholar
  36. 36.
    Tobias JD, Schleien C (1991) Granulocyte transfusions – a review for the intensive care physician. Anaesth Intensive Care 19:512–520PubMedGoogle Scholar
  37. 37.
    Froland SS (1984) Bacterial infections in the compromised host. Scand J Infect Dis Suppl 43:7–16PubMedGoogle Scholar
  38. 38.
    Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340PubMedCrossRefGoogle Scholar
  39. 39.
    Dale DC, Guerry D, Wewerka JR, Bull JM, Chusid MJ (1979) Chronic neutropenia. Medicine (Baltimore) 58:128–144CrossRefGoogle Scholar
  40. 40.
    Kobayashi SD, Voyich JM, Braughton KR et al (2004) Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 172:636–643PubMedGoogle Scholar
  41. 41.
    Bunting M, Harris ES, McIntyre TM, Prescott SM, Zimmerman GA (2002) Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol 9:30–35PubMedCrossRefGoogle Scholar
  42. 42.
    Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247PubMedCrossRefGoogle Scholar
  43. 43.
    Rahman I, Biswas SK, Kode A (2006) Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 533:222–239PubMedCrossRefGoogle Scholar
  44. 44.
    Temple MD, Perrone GG, Dawes IW (2005) Complex cellular responses to reactive oxygen species. Trends Cell Biol 15:319–326PubMedCrossRefGoogle Scholar
  45. 45.
    Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365–376PubMedCrossRefGoogle Scholar
  46. 46.
    Altieri DC (1995) Proteases and protease receptors in modulation of leukocyte effector functions. J Leukoc Biol 58:120–127PubMedGoogle Scholar
  47. 47.
    Zaidi SH, You XM, Ciura S, Husain M, Rabinovitch M (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105:516–521PubMedCrossRefGoogle Scholar
  48. 48.
    Zeiher BG, Matsuoka S, Kawabata K, Repine JE (2002) Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med 30:S281–S287PubMedCrossRefGoogle Scholar
  49. 49.
    Ganz T (2004) Antimicrobial polypeptides. J Leukoc Biol 75:34–38PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  • Harry L. Malech
    • 1
  • Frank R. DeLeo
    • 2
  • Mark T. Quinn
    • 3
  1. 1.Laboratory of Host DefensesNational Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesdaUSA
  2. 2.Laboratory of Human Bacterial Pathogenesis, Rocky Mountain LaboratoriesNational Institute of Allergy and Infectious Diseases, National Institutes of HealthHamiltonUSA
  3. 3.Department of Microbiology and ImmunologyMontana State UniversityBozemanUSA

Personalised recommendations